resistance in braf and kras mutant cancers
Published 9 years ago • 128 plays • Length 47:45Download video MP4
Download video MP3
Similar videos
-
47:45
resistance in braf and kras mutant cancers - by ryan corcoran, md, phd
-
21:11
resistance to mapk pathway inhibition in braf mutant colorectal cancers
-
5:14
braf mutations across cancers
-
6:28
what is braf, ras (k ras, n ras)? can these genes be mutated?
-
0:30
kras in the setting of colon cancer
-
15:57
braf mutation – what does it mean? what are the complications of braf inhibitors?
-
2:25
cancer cell biology: mutated kras & reciprocal signalling
-
7:46
personalized therapies for patients with kras-mutant lung cancer
-
6:21
braf and ras mutation status in colorectal cancer
-
1:11
what is a kras mutation?
-
32:30
braf: the first prevalent oncogene target to show single-agent responsiveness
-
4:29
mechanisms of acquired resistance to kras g12c inhibition in cancer
-
3:03
braf: from gene to cancer therapy
-
1:34
new directions in targeting the multifaceted braf in cancer | oncotarget
-
45:19
mutation based resistance to tki therapy
-
1:43
survival differences in kras/braf mutations in mcrc
-
2:01
review of a case of coexisting kras and braf mutations in a patient with metastatic colon
-
7:57
case 3: kras-mutated metastatic colon cancer
-
2:33
braf mutations in colorectal cancer
-
1:07
the case for separating g12d mutations in studying kras-mutant pdac
-
1:37
treatment strategies for kras-mutant nsclc with co-mutations
-
0:41
improving outcomes in kras-mutant pancreatic cancer